{"id":774572,"date":"2023-08-02T10:05:31","date_gmt":"2023-08-02T14:05:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/"},"modified":"2023-08-02T10:05:31","modified_gmt":"2023-08-02T14:05:31","slug":"apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/","title":{"rendered":"Apogee Therapeutics to Participate in Upcoming August Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN FRANCISCO and WALTHAM, Mass., Aug.  02, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pxTZA-Stz9EADyPj25g_4kX6yC0ZIlxDXC-PQuwQMSv4BFZ_mdxqr2KW-ib9I1DZzIssIPiPmGkhqjiU4qG__KckegN4e1_-pH3bGR_jrHBh1mrtpadyiJmS3Se0bVmmYYaQ1WSIGOYa-bRrGMa74yyQk2Gv1ZmyXtFygjjRu3T0PyFykzUrafNYsFKJidXTl9CS5Mh4QDbHDiuRv6wk_suAIipu3ZvPaQLt-0muocR9oxwO-AjKuh4oLtMID-wQk-v5hsJfLYZ5qp03uHVlf30Iv2UpB1qDZlxj5rZN67a4cEzA5S_W3X4VBiywVn3eb3BPrMBVfm-BKKGhWt39qyNT6Dduv9gS2u8rnNx4AHBxZZIyNq-DvrP9ilVwNrWg\" rel=\"nofollow noopener\" target=\"_blank\">Apogee Therapeutics, Inc.<\/a> (Nasdaq: APGE), a biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease and other inflammatory and immunology indications, today announced that management will participate in the following upcoming investor conferences:<\/p>\n<ul type=\"disc\">\n<li>2023 Wedbush PacGrow Healthcare Conference &#8211; August 8, 2023<\/li>\n<li>Stifel Biotech Summer Summit &#8211; August 14-16, 2023<\/li>\n<\/ul>\n<p>\n        <strong>About Apogee Therapeutics<\/strong>\n      <\/p>\n<p>Apogee Therapeutics, Inc. (Nasdaq: APGE) is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (\u201cAD\u201d), chronic obstructive pulmonary disease (\u201cCOPD\u201d) and other inflammatory and immunology indications with high unmet need. Apogee\u2019s antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. The Company\u2019s two most advanced programs are APG777 and APG808, which are being initially developed for the treatment of AD and COPD, respectively. Based on a broad pipeline and depth of expertise, the Company believes it can deliver value and meaningful benefit to patients underserved by today\u2019s standard of care. For more information, please visit www.apogeetherapeutics.com.<\/p>\n<p>\n        <strong>Investor Contacts:<\/strong>\n      <\/p>\n<p>Noel Kurdi<br \/>VP of Investor Relations<br \/>Apogee Therapeutics<br \/>noel.kurdi@apogeetherapeutics.com<\/p>\n<p>Chelcie Lister<br \/>THRUST Strategic Communications<br \/>chelcie@thrustsc.com<\/p>\n<p>\n        <strong>Media Contact:<\/strong>\n      <\/p>\n<p>Dan Budwick<br \/>1AB Media<br \/>dan@1abmedia.com<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTE5NSM1NzMxNDMwIzIyNTkyMjc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NDE2ZDZlMTAtZWNiYi00ODM1LTgyZTItOGZlMzVlMmY0Mzk2LTEyNzA3Nzc=\/tiny\/Apogee-Therapeutics-LLC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN FRANCISCO and WALTHAM, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) &#8212; Apogee Therapeutics, Inc. (Nasdaq: APGE), a biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease and other inflammatory and immunology indications, today announced that management will participate in the following upcoming investor conferences: 2023 Wedbush PacGrow Healthcare Conference &#8211; August 8, 2023 Stifel Biotech Summer Summit &#8211; August 14-16, 2023 About Apogee Therapeutics Apogee Therapeutics, Inc. (Nasdaq: APGE) is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (\u201cAD\u201d), chronic obstructive pulmonary disease (\u201cCOPD\u201d) and other inflammatory and immunology indications with high unmet need. Apogee\u2019s antibody programs are designed to overcome limitations of existing therapies by targeting well-established &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Apogee Therapeutics to Participate in Upcoming August Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-774572","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Apogee Therapeutics to Participate in Upcoming August Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Apogee Therapeutics to Participate in Upcoming August Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO and WALTHAM, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) &#8212; Apogee Therapeutics, Inc. (Nasdaq: APGE), a biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease and other inflammatory and immunology indications, today announced that management will participate in the following upcoming investor conferences: 2023 Wedbush PacGrow Healthcare Conference &#8211; August 8, 2023 Stifel Biotech Summer Summit &#8211; August 14-16, 2023 About Apogee Therapeutics Apogee Therapeutics, Inc. (Nasdaq: APGE) is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (\u201cAD\u201d), chronic obstructive pulmonary disease (\u201cCOPD\u201d) and other inflammatory and immunology indications with high unmet need. Apogee\u2019s antibody programs are designed to overcome limitations of existing therapies by targeting well-established &hellip; Continue reading &quot;Apogee Therapeutics to Participate in Upcoming August Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-02T14:05:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTE5NSM1NzMxNDMwIzIyNTkyMjc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Apogee Therapeutics to Participate in Upcoming August Investor Conferences\",\"datePublished\":\"2023-08-02T14:05:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\\\/\"},\"wordCount\":223,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NTE5NSM1NzMxNDMwIzIyNTkyMjc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\\\/\",\"name\":\"Apogee Therapeutics to Participate in Upcoming August Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NTE5NSM1NzMxNDMwIzIyNTkyMjc=\",\"datePublished\":\"2023-08-02T14:05:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NTE5NSM1NzMxNDMwIzIyNTkyMjc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NTE5NSM1NzMxNDMwIzIyNTkyMjc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Apogee Therapeutics to Participate in Upcoming August Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Apogee Therapeutics to Participate in Upcoming August Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Apogee Therapeutics to Participate in Upcoming August Investor Conferences - Market Newsdesk","og_description":"SAN FRANCISCO and WALTHAM, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) &#8212; Apogee Therapeutics, Inc. (Nasdaq: APGE), a biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease and other inflammatory and immunology indications, today announced that management will participate in the following upcoming investor conferences: 2023 Wedbush PacGrow Healthcare Conference &#8211; August 8, 2023 Stifel Biotech Summer Summit &#8211; August 14-16, 2023 About Apogee Therapeutics Apogee Therapeutics, Inc. (Nasdaq: APGE) is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (\u201cAD\u201d), chronic obstructive pulmonary disease (\u201cCOPD\u201d) and other inflammatory and immunology indications with high unmet need. Apogee\u2019s antibody programs are designed to overcome limitations of existing therapies by targeting well-established &hellip; Continue reading \"Apogee Therapeutics to Participate in Upcoming August Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-02T14:05:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTE5NSM1NzMxNDMwIzIyNTkyMjc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Apogee Therapeutics to Participate in Upcoming August Investor Conferences","datePublished":"2023-08-02T14:05:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/"},"wordCount":223,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTE5NSM1NzMxNDMwIzIyNTkyMjc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/","name":"Apogee Therapeutics to Participate in Upcoming August Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTE5NSM1NzMxNDMwIzIyNTkyMjc=","datePublished":"2023-08-02T14:05:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTE5NSM1NzMxNDMwIzIyNTkyMjc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NTE5NSM1NzMxNDMwIzIyNTkyMjc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apogee-therapeutics-to-participate-in-upcoming-august-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Apogee Therapeutics to Participate in Upcoming August Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/774572","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=774572"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/774572\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=774572"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=774572"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=774572"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}